Central Florida Pulmonary Group, PA — Orlando, Florida

Central Florida Pulmonary Group, PA is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Central Florida Pulmonary Group, PA has participated in 25 clinical trials with 3 currently active.

Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis.

Sponsors: Vertex Pharmaceuticals Incorporated, Kadmon Corporation, LLC, United Therapeutics.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Florida Pulmonary Group, PA?

Central Florida Pulmonary Group, PA has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Florida Pulmonary Group, PA conducted?

Central Florida Pulmonary Group, PA has 25 clinical trials on record, with 3 currently active. Their work covers Alpha 1-Antitrypsin Deficiency, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis.

Is Central Florida Pulmonary Group, PA accredited by Crixeo Health?

Yes — Central Florida Pulmonary Group, PA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Central Florida Pulmonary Group, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.